Advertisement

Topics

CP2D/AS-3 Blood Collection and Sampling System | Nutricel Additive Solution - CP2D [Haemonetics Manufacturing Inc.] | BioPortfolio

12:38 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

CP2D/AS-3 Blood Collection And Sampling System with Nutricel Additive System

Instruction for Use for Systems Containing a Y Sampling Site (YSS) or Sample Diversion Pouch (with or without a pre-attached SampLok® Vacuum Tube Holder).

Refer to unit foil package label for specific product description being used.

Sterile, nonpyrogenic fluid path. Sterilized by steam.

Rx only.

This product is free of natural rubber latex.

For collection of blood and preparation of red blood cells, plasma and platelets.

Warning: Failure to achieve and maintain a closed system during processing would result in a product that must be transfused within 24 hours.

Use aseptic technique. Use only if solutions are clear. If preparing a platelet concentrate, the platelet-rich plasma should be separated from the red blood cells within 8 hours after blood collection. If preparing fresh frozen plasma, separate from the red blood cells and place in the freezer at -18 °C or colder within 8 hours after collection. Store CP2D/AS-3 preserved red blood cells at 1—6 °C for up to 42 days and use as indicated.

* During processing, always observe the following precautions:

1. Sealing should be done in a manner that avoids fluid splatter.

2. Always dispose of blood-contaminated products in a manner consistent with established BIOHAZARD safety procedures

Store CP2D/AS-3 preserved red blood cells at 1—6 °C for up to 42 days and use as indicated.

1. Load blood agitation device or suspend blood bag on donor scale and adjust donor scale to desired collection gross weight as per manufacturer's instructions.

2. Clamp donor tubing between DonorCare® Needle Guard (DCNG) and Y Sampling Site.

3. Secure donor tubing above the Y connector and disinfect site of phlebotomy.

4. If using blood pressure cuff, inflate to not more than 60 mm Hg.

5. Remove donor needle cover and accomplish phlebotomy.

6. Release clamp and ensure there is blood flow. Reduce pressure as required.

7. Slide the DCNG midway over the needle hub and securely tape DCNG to the donor's arm as close to the top of the DCNG as possible. Note: If blood flow is slow, slide DCNG away from the needle hub, adjust and re-engage DCNG. If repeated needle adjustment is necessary, slide DCNG away from the needle hub and re-engage at the end of blood collection.

8. Collect appropriate volume of blood into collection bag, as indicated on packaging.

Note: Mix blood and anticoagulant frequently during collection, for example, once every 45 seconds, and immediately after collection. If blood agitation device is used, follow manufacturer's operating instructions.

9. After required amount of blood has been collected, seal donor tubing close to Y Sampling Site.*

10. For blood sampling, remove the Y Sampling Site needle cover. Ensure the protective sheath is in place over the sampling needle.

11. Fasten the vacuum tube holder on to the base of the sampling needle.

12. Collect blood samples into vacuum tubes.

13. Ensure the vacuum tubes are centered within the vacuum tube holder during sample collection.

14. Maintain forward pressure on the vacuum tubes during sample collection.

Note: After the last tube is collected, it is recommended that the vacuum tube holder be left in place.

15. After blood samples are collected, clamp donor tubing between the Y Sampling Site and DCNG, and as close to the DCNG as possible.

16. Release any remaining pressure from the donor's arm.

17. DCNG must be held stationary while the needle is withdrawn into it. While holding sides of DCNG near the front, grasp the tubing below the clamp and pull the needle into the DCNG until it locks into place, and the needle hub engages the bottom of the DCNG.

18. Insert the DCNG into the vacuum tube holder. Note: It is recommended that the DCNG be inserted securely into the vacuum tube holder, prior to discarding.

19. Seal donor tubing adjacent to DCNG.* Detach and discard needle, DCNG,Y Sampling Site and tubing.*

20. Strip tubing between seal and collection bag.

21. Continue to “Processing Instructions”, Section IV, Step 1.

When using systems with a pre-attached SampLok vacuum tube holder, follow instructions as noted below, but refer to Section III when indicated to do so.

1. Load blood agitation device or suspend blood bag on donor scale and adjust donor scale to desired collection gross weight as per manufacturer's instructions.

2. Clamp donor tubing between DonorCare Needle Guard (DCNG) and Sampling Site.

3. Secure donor tubing above the Y connector and disinfect site of phlebotomy.

4. If using blood pressure cuff, inflate to not more than 60 mm Hg.

5. Remove donor needle cover and accomplish phlebotomy.

6. Release clamp and ensure there is blood flow.

7. Slide the DCNG midway over the needle hub and securely tape DCNG to the donor's arm as close to the top of the DCNG as possible. Note: If blood flow is slow, slide DCNG away from the needle hub, adjust and re-engage DCNG. If repeated needle adjustment is necessary, slide DCNG away from the needle hub and re-engage at the end of blood collection.

8. The donor blood will be automatically diverted to the sample diversion pouch. Once the sample diversion pouch is filled, close clamp immediately on tubing between the sample diversion pouch and Y connector. Warning: To avoid risk of air embolism to donor, do not squeeze sample diversion pouch while tubing is open.

9. Open snap-open closure between the Y connector and the collection bag to initiate blood collection. Reduce pressure as needed.

10. Permanently seal tubing between the sample diversion pouch and the Y connector to maintain sterility of the system prior to collecting blood samples.

*Note: When using systems with a pre-attached SampLok vacuum tube holder, go to Section III.

11. For blood sampling, remove the Sampling Site needle cover. Ensure the protective sheath is in place over the sampling needle.

12. Fasten the vacuum tube holder on to the base of the sampling needle.

13. Position the sample diversion pouch downwards so that the air rises to the top of the pouch and away from the vacuum tube holder. Note: Drawing air into the vacuum tube may cause hemolysis.

14. Collect blood samples from the sample diversion pouch into vacuum tubes within approximately four minutes to avoid possible clot formation.

15. Ensure the vacuum tubes are centered within the vacuum tube holder during sample collection.

16. Maintain forward pressure on the vacuum tubes during sample collection.

Note: After the last tube is collected, it is recommended that the vacuum tube holder be left in place.

17. Collect appropriate volume of blood into collection bag as indicated on packaging.

Note: Mix blood and anticoagulant frequently during collection, for example, once every 45 seconds, and immediately after collection. If blood agitation device is used, follow manufacturer's operating instructions.

18. After required amount of blood has been collected, seal donor tubing close to snap-open closure.*

19. Clamp donor tubing between the Y connector and DCNG, as close as possible to the DCNG.

20. Release any remaining pressure from donor's arm.

21. DCNG must be held stationary while the needle is withdrawn into it. While holding sides of DCNG near the front, grasp the tubing below the clamp and pull the needle into the DCNG until it locks into place, and the needle hub engages the bottom of the DCNG.

22. Insert the DCNG into the vacuum tube holder, if desired. Note: It is recommended that the DCNG be inserted securely into the vacuum tube holder, prior to discarding.

23. Seal donor tubing adjacent to DCNG.* Detach and discard needle, DCNG, sample diversion pouch and tubing.*

24. Strip tubing between seal and collection bag.

25. Continue to “Processing Instructions”, Section IV, Step 1.

1. To collect blood samples, open lid from SampLok vacuum tube holder.

2. Open snap-open closure between sample diversion pouch and SampLok vacuum tube holder.

3. Position the sample diversion pouch downwards so that the air rises to the top of the pouch and away from the SampLok vacuum tube holder. Note: Drawing air into the vacuum tube may cause hemolysis.

4. Collect blood samples from the sample diversion pouch into vacuum tubes within approximately four minutes to avoid possible clot formation.

5. Ensure the vacuum tubes are centered within the SampLok vacuum tube holder during sample collection.

6. Maintain forward pressure on the vacuum tubes during sample collection.

7. The lid may be closed on the SampLok vacuum tube holder after sample collection.

8. Return to Section II, Step 17. Note: When collection of unit is complete, and the donor needle is engaged in the DCNG, open the lid of the SampLok vacuum tube holder and insert the DCNG into the holder. Twist until it locks into place. An audible click will confirm that it is locked.

1. Process whole blood within 72 hours of collection.

2. Mix whole blood/anticoagulant thoroughly.

3. Load whole blood and satellite bags into centrifuge cup, ensuring that the tubing stays in the top half of the cup.

4. Centrifuge at appropriate conditions to produce desired components.

5. Carefully remove the unit from the centrifuge and place the red cell storage bag in the plasma expressor.

6. Clamp tubing to extra satellite bags, if present.

7. Gently apply expressor pressure.

8. Open snap-open closure to satellite bag and express plasma.

9. After plasma is expressed, clamp tubing between red cell storage bag and Y connector, and release expressor pressure.

10. Clamp tubing between the Y connector and plasma bag.

11. Hang AS-3 bag above red cell storage bag and remove clamp from tubing to the red cell storage bag.

12. Open snap-open closure on the bag containing the AS-3 additive solution and transfer to the bag containing the red cells. Note: AS-3 solution should be added to the packed red blood cells immediately after removal of plasma.

Transfer AS-3 solution under one of the following processing conditions:

a. within 8 hours of collection if whole blood is held at room temperature.

b. within 72 hours of collection if whole blood is refrigerated.

13. Seal tubing and detach the bag containing packed red cells, and set aside plasma for further processing.*

14. Gently mix packed red cells and AS-3 solution.

15. Store CP2D/AS-3 preserved red blood cells at 1—6 °C for up to 42 days and use as indicated. Note: If AS-3 is not used, whole blood or red blood cells in CP2D alone may be stored at 1—6 °C for up to 21 days.

Each shipping case contains 8 foil envelopes. Within each foil envelope resides 3 clear pouches containing an individual collection system. Each unit consists of a collection bag with 70ml of CP2D solution, an additive bag with 110ml of AS-3 solution, and two empty CLX bags.

AS-3 RED BLOOD CELLS ADENINE-SALINE ADDED 16.5 mEq sodium added

From 500ml CP2D Whole Blood Store at 1—6 °C

Anticoagulant Citrate Phosphate Double Dextrose Solution

70ml Anticoagulant Citrate Phosphate Double Dextrose Solution for collection of 500ml of blood. Each 70ml of CP2D solution contains 3.57g dextrose (monohydrate), USP; 1.84g sodium citrate (dihydrate), USP; 0.229g citric acid (monohydrate), USP; and 0.155g monobasic sodium phosphate (monohydrate), USP. Use only if solution is clear.

See circular of information for indications, contraindications, cautions and methods of infusion. VOLUNTEER DONOR. This product may transmit infectious agents. Rx only. PROPERLY IDENTIFY INTENDED RECIPIENT.

CP2D 500

121-93

Red cell storage in CLX bag limited to 21 days. Store platelets 5 days at 20—24°C

CLX Container CP2D 500

See circular of information for indications, contraindications, cautions and methods of infusion. VOLUNTEER DONOR. This product may transmit infectious agents. Rx only. PROPERLY IDENTIFY INTENDED RECIPIENT.

121-93

CP2D/AS-3 500ml

BLOOD COLLECTION SYSTEM with Nutricel Additive Solution

CP2D/AS-3 Triple with Sample Diversion Pouch

For collection of 500ml of blood and preparation of red blood cells, plasma and platelets

Each unit consists of a collection bag with 70ml of CP2D solution, an additive bag with 110ml of AS-3 solution, and two empty CLX satellite bags. Each 70ml of CP2D solution contains 3.57 g dextrose (monohydrate), USP; 1.84g sodium citrate (dihydrate), USP; 0.229 g citric acid (monohydrate), USP; and 0.155g monobasic sodium phosphate (monohydrate), USP. Each 110ml of AS-3 solution contains 1.21 g dextrose (monohydrate), USP; 0.647 g sodium citrate (dihydrate), USP; 0.451 g sodium chloride, USP; 0.304 g monobasic sodium phosphate (monohydrate), USP; 0.046 g citric acid (monohydrate), USP; and 0.033 g adenine, USP.

Sterile, non pyrogenic fluid path. Sterilized by steam. See accompanying directions for use. Rx only. Store at room temperature. Unused bags in opened pouches may be kept 30 days by folding and SECURING open end of pouch to prevent possible loss of moisture.

3 Units Code 121-93

HAEMONETICS, THE Blood Management Company and Nutricel are registered trademarks of Haemonetics Corporation. DonorCare and SampLok are registered trademarks of ITL Corporation, Canberra, Australia.

Manufactured for: Haemonetics Corporation

400 Wood Road

Braintree, MA 02184, USA

By: Haemonetics Manufacturing Inc

1630 Industrial Park Street

Covina, CA 91722, USA

Visit us at www.haemonetics.com

Phone: 888.489.5938

Manufacturer

Haemonetics Manufacturing Inc.

Active Ingredients

Source

Drugs and Medications [22 Associated Drugs and Medications listed on BioPortfolio]

Rejuvesol [citra labs llc]

rejuvesol red blood cell processing solution

Nutricel additive system - cp2d [haemonetics manufacturing inc]

CP2D/AS-3 Blood Collection and Sampling System

Nutricel additive system - cp2d [medsep corporation]

CP2D/AS-3 Blood Collection and Sampling System

Nutricel additive solution - cp2d [haemonetics manufacturing inc.]

CP2D/AS-3 Blood Collection and Sampling System

Haemonetics additive solution formula 3 (as-3) [haemonetics corporation]

Haemonetics Additive Solution Formula 3 (AS-3)

Clinical Trials [2069 Associated Clinical Trials listed on BioPortfolio]

Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma

The purpose of this study is to evaluate the clinical efficacy of transfusions with platelets stored in platelet additive solution II compared to plasma storage.

Clinical Study to Assess the Performance of the Dialyzer With Endexo™

EndexoTM is an additive that is blended into the fiber solution during manufacturing of the hemodialyzer hollow fibers. The intended purpose of the additive is to increase blood compatibil...

Cold Apheresis Platelets in Isoplate

This is a platelet transfusion study. The purpose of this study is to measure the life span and quality of platelets preserved in an additive solution and stored in a refrigerator. Partici...

Evaluation of Questionnaires of Tumor Patients With and Without Additive Homeopathic Therapy

Tumor patients receiving conventional tumor therapies may choose to receive additional homeopathic therapy. The patients are randomized into two groups receiving either additive homeopathi...

In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution

The purpose of this study is to evaluate the quality of platelets collected on the Trima Accel system after storage for 5 days in a Platelet Additive Solution (PAS), called InterSol.

PubMed Articles [4380 Associated PubMed Articles listed on BioPortfolio]

Platelet storage in more than 90% additive solution containing glucose and bicarbonate has the potential to increase shelf life.

Platelet concentrates (PCs) suspended in more than 90% additive solution (AS) are recommended for patients with reactions to platelets stored in plasma. Next-generation AS containing glucose and bicar...

Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy.

Platelet inventory constraints can result in minor ABO incompatibility and possible hemolysis. The aims of this study were to determine the reduction of isoagglutinin in titers of platelets stored in ...

Removal of Sr using high-surface-area hydroxyapatite synthesized by non-additive in-situ precipitation.

Owing to their high-risk factor, many attempts have been made to remove radionuclides from water. Sr ions are the target of removal by synthesized hydroxyapatite in this research. A facile method for ...

To STABILISE or not: Is the additive time of additive benefit?

Additive-based stability assessment of biologically designed CuO and GSH-CuO nanospheres and their applicability as Nano-biosensors.

Uncapped and Glutathione capped Cupric oxide nanospheres were synthesized by the interaction of Berberis lycium (Bl) root extract with corresponding salt solution. CuO nanospheres were best optimized ...

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record